Haoyu Wang

Haoyu Wang

Auto-generated profile, based on publicly available information

Haoyu Wang

Children’s Hospital of Nanjing Medical University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
PDF file
MKMatthew P. Kosloski
Matthew P. Kosloski
DBDaniel A.J. Bow
Daniel A.J. Bow
RKRyota Kikuhchi
Ryota Kikuhchi
HWHaoyu Wang
Haoyu Wang
EKElaine J. Kim
Elaine J. Kim
WLWei Liu
Wei Liu
Glecaprevir and pibrentasvir are oral direct-acting antiviral agents approved in combination for treatment of chronic hepatitis C viral infection. In vitro studies identified the combination as potential clinically relevant inhibitors of the efflux transporters P glycoprotein (P-gp), breast cancer resistance protein (BCRP), and hepatic uptake transporters organic anion transporting polypeptide (OATP) 1B1/3. Glecaprevir inhibited P-gp, BCRP, OATP1B1, and OATP1B3 with IC50 values of 0.33, 2.3, 0.017, and 0.064 µM, respectively. Pibrentasvir inhibited P-gp, BCRP, and OATP1B1 with IC50 values of 0.036, 14, and 1.3 µM, respectively. Neither agent inhibited organic cation transporter (OCT) 1, OCT2, organic anion transporter (OAT) 1, OAT3, multidrug and toxin extrusion (MATE) 1, or MATE2K. Open-label Phase 1 clinical drug-drug interaction studies were conducted in healthy subjects to evaluate interaction potential of glecaprevir/pibrentasvir and coadministered selective substrates for P-gp (digoxin, dabigatran etexilate, sofosbuvir), BCRP (rosuvastatin, sofosbuvir), and OATP1B1/3 (pravastatin, rosuvastatin). Pharmacokinetic parameters maximum plasma concentration (Cmax) and area under the plasma concentration-time curve (AUC) were evaluated for probe substrates alone and in combination with glecaprevir/pibrentasvir. Cmax central values increased by 72%, 105%, 123%, 462%, and 66% for digoxin, dabigatran, pravastatin, rosuvastatin, and sofosbuvir, respectively. AUC central values increased by 48%, 138%, 130%, 115%, and 125% for digoxin, dabigatran, pravastatin, rosuvastatin, and sofosbuvir, respectively. Exposure of sofosbuvir metabolite GS-331007 was similar with or without glecaprevir/pibrentasvir. Outcomes of the clinical drug-drug interaction studies confirmed clinically relevant inhibition of P-gp, BCRP, and OATP1B1/3, and were used to provide dosing guidance for the concomitant use of glecaprevir/pibrentasvir with relevant transporter substrates. SIGNIFICANCE STATEMENT N/A

8 January 2024 in Phytomedicine
Verified
Journal Article
Closed access
GHGuan-Gen Huang
Guan-Gen Huang
HWHaoyu Wang
Haoyu Wang
XWXiao-Han Wang
Xiao-Han Wang
TYTao Yang
Tao Yang
XZXiao-Meng Zhang
Xiao-Meng Zhang
WTWei Tang
Wei Tang

12 March 2021 in Food & Function
Verified
Journal Article
Closed access
PDF file
Ningning HeNingning He
Ningning He
HCHao Chen
Hao Chen
ZZZihan Zhou
Zihan Zhou
WZWandong Zhao
Wandong Zhao
SWShuo Wang
Shuo Wang
SLShangyong Li
Shangyong Li
The composition and structure of gut microbiota plays an important role in obesity induced by a high-fat diet (HFD) and related metabolic syndrome (MetS).

19 October 2018 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
MKMatthew P. Kosloski
Matthew P. Kosloski
HWHaoyu Wang
Haoyu Wang
DPDavid Pugatch
David Pugatch
FMFederico J. Mensa
Federico J. Mensa
EGEdward Gane
Edward Gane
WLWei LIU
Wei LIU

4 May 2023 in E3S Web of Conferences
Verified
Conference Paper
Open access
PDF file
HWHaoyu Wang
Haoyu Wang
GWGuanghao Wei
Guanghao Wei
Chemical synthesis is a powerful tool for human being as it provides many useful products, especially those that do not exist or only exist in a small quantity in nature. Since it is often hard to design and visualize the reactions of organic synthesis, retrosynthesis is often used to achieve a desired product. This review is an introduction of the concepts of retrosynthetic analysis and how it can be established, including the basic steps and strategies. It also discuss the guiding principles of retrosynthesis (simplification, complexity, yield) along with some possible problems and coping strategies in the analyses, including functional group disconnections, fine tuning, and illogical disconnections.

3 November 2025 in Neuroscience
Verified
Journal Article
Closed access
CCChen-Chao Chu
Chen-Chao Chu
YHYa-Hui Hu
Ya-Hui Hu
HZHai-Feng Zhang
Hai-Feng Zhang
GLGui-Zhou Li
Gui-Zhou Li
SWShi-Yu Wu
Shi-Yu Wu
FCFeng Chen
Feng Chen